Background: The worldwide COVID-19 pandemic was caused by a newly discovered
Coronavirus. The treatment methods for COVID-19 are emerging and rapidly evolving …

Objectives COVID-19 patients suffer from the lack of curative therapy. Hence, there is an
urgent need to try repurposed old drugs on COVID-19. Methods Randomized controlled …

Background: A definitive treatment of SARS CoV-2 is yet to arrive and the human death toll
rises exponentially globally. In this health emergency, it might be useful to look into the old …

Objective We evaluated whether ivermectin combined with doxycycline reduced the clinical
recovery time in adults with COVID-19 infection. Methods This was a randomized, blinded …

During the first year of the COVID-19 pandemic, unauthorized drugs were widely used.
Ivermectin and hydroxychloroquine are drugs that inhibit viral replication in vitro and that …

Background To date no effective therapy has been demonstrated for COVID-19. In vitro,
studies indicated that ivermectin (IVM) has antiviral effect. Objectives To assess the …

Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to
inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A …

Researchers around the world are working at record speed to find the best ways to treat and
prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of …

Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …

Background and objectives: Various existing non-antiviral drugs are being used to treat
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based mostly on …